BUZZ-Australia's Mayne Pharma hits over 2-year low on board resizing

Reuters
Jan 14
BUZZ-Australia's <a href="https://laohu8.com/S/MYX.AU">Mayne Pharma</a> hits over 2-year low on board resizing

** Shares of Mayne Pharma MYX.AX slip 1.66% to A$2.96, their lowest since mid-October 2023

** Pharma co to cut board's size, says move is in its best interests

** Under revamp, Chair Frank Condella to exit on Wednesday; two non-executive directors to follow post-February results

** Co names Bruce Robinson, a non-executive director since 2014, as non-executive chair

** Stock fell 37.4% last year

(Reporting by Kumar Tanishk in Bengaluru)

((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk http://www.x.com/thatstanishk;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10